Politics
Impact of GLP-1 Drugs on Substance Use Disorder Diagnoses
A recent study indicates that individuals using GLP-1 medications such as Ozempic for diabetes management show a lower incidence of substance use disorder diagnoses.
Editorial Staff
1 min read
Recent findings highlight the potential implications of GLP-1 drugs, particularly in their role in diabetes treatment and weight management.
The study revealed that patients on GLP-1 medications were statistically less likely to receive a diagnosis of substance use disorder.
This correlation raises questions about the broader impacts of GLP-1s on behavioral health and their potential role in addiction prevention.